Home/Filings/4/0001140361-18-032937
4//SEC Filing

van Elsas Andrea 4

Accession 0001140361-18-032937

CIK 0001435049other

Filed

Jul 18, 8:00 PM ET

Accepted

Jul 19, 7:39 PM ET

Size

5.2 KB

Accession

0001140361-18-032937

Insider Transaction Report

Form 4
Period: 2018-07-17
van Elsas Andrea
Chief Scientific Officer
Transactions
  • Sale

    Common Stock

    2018-07-17$6.96/sh10,454$72,803206,215 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2018.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.875 to $7.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Documents

1 file

Issuer

ADURO BIOTECH, INC.

CIK 0001435049

Entity typeother

Related Parties

1
  • filerCIK 0001714425

Filing Metadata

Form type
4
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 7:39 PM ET
Size
5.2 KB